Melbourne Biomedical Precinct based group for organisations with interests in therapeutics development
small molecules • biologics • cell therapies
MTx vision
To build a robust local network of organisations, across academia and industry, that competes globally in novel medicine development based on precinct biomedical discoveries.
21 members across academic and affiliated organisations, biotech, private companies, translation and commercialisation groups, and government
We are
Advocate for an enhanced precinct approach to therapeutic development.
Foster an ecosystem for the translation of local biomedical discoveries into new medicines.
Create a strong network of collaborations across organisations.
Build capacity and capability in translational activities.